Gov. Mikie Sherrill said she will build on the harm reduction programs established by her predecessor, strategies that ...

There are many different ways to quantify the opioid crisis. The obvious is the dramatic rise in deaths from overdoses. Let’s not overlook the number of overdoses themselves – often as recorded by ...

Like many who have endured childhood trauma, Shannon Hicks turned to drugs at an early age. Pregnant by 16 and a mother of two by 19, she was married and living in her first home — believing she was ...

MINOT — To understand why harm reduction works, as a public policy, we must first consider what doesn’t work. Prohibition doesn’t work. We tried it with alcohol, and it was one of the most spectacular ...

A Q&A with Emanuel Roberts, who runs a North Minneapolis nonprofit committed to getting drug users safe and into recovery any way possible ...

There has been a lot of attention on the charges filed against the former COO of the Harm Reduction Coalition of San Diego involving alleged misuse of county grant funds that were designated for ...

September is Recovery Month, a time to celebrate people who’ve overcome their addictions and honor those we’ve lost to overdose. Overdose is a leading cause of death for people forced to live outside, ...

Opioids, including the best known—morphine, heroin and fentanyl—have been gaining popularity over the last few decades. Although officially banned, these painkillers still find their way into prisons ...

In the landscape of addiction treatment, we often find ourselves searching for approaches that honor the fundamental human need for connection. Harm reduction, frequently misunderstood, offers more ...

Inside a bright new building in the heart of Skid Row, homeless people hung out in a canopy-covered courtyard — some waiting to take a shower, do laundry, or get medication for addiction treatment.

Research suggests the drugs have potential for prevention and harm reduction in substance use disorders, writes Ziyad Al-Aly People taking glucagon-like peptide-1 (GLP-1) receptor agonists often ...